Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 6 hours agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Eli Lilly exec expects obesity pill data in April 2025
Reuters· 4 hours agoDrugs from the class are also being tested to treat Alzheimer's. Patrik Jonsson, President of Lilly...
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 3 hours agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...
What's Next for Eli Lilly Stock After Alzheimer's Drug Gets Nod From FDA Panel?
TheStreet.com· 59 minutes agoLet's check the charts for guidance. Pharmaceutical giant Eli Lilly (LLY) has reached another record...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab – KION546
KION 46 Salinas· 31 minutes agoOne in three older Americans dies with Alzheimer’s disease or another form of dementia, according to...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 6 hours agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Eli Lilly and Co LLY . And retail traders should know. We noticed ...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 13 hours agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance via AOL· 7 hours agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
WSAU Wausau· 5 hours ago(Reuters) - A top Eli Lilly executive said on Monday that more patients are paying the full list...
Shell Asset Management Co. Sells 12,465 Shares of Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 13 hours agoShell Asset Management Co. lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 21.7% in the fourth quarter, Holdings Channel.com ...